Detalhe da pesquisa
1.
Frequency and outcomes of obinutuzumab-induced thrombocytopenia.
Br J Haematol
; 203(4): 668-672, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37853574
2.
Chromosome microarray characterisation of chromosome arm 12p loss associated with complex molecular karyotype and recurrent adverse cytogenetic markers in multiple myeloma.
Genes Chromosomes Cancer
; 60(10): 668-677, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34041820
3.
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients.
Am J Hematol
; 95(12): 1511-1521, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32833294
4.
Characteristics of patients with myelodysplastic syndrome with balanced translocations.
Br J Haematol
; 190(2): 244-248, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32181489
5.
Pregnancy outcomes in myeloproliferative neoplasms: A Mayo Clinic report on 102 pregnancies.
Am J Hematol
; 95(5): E114-E117, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32020655
6.
Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors.
J Immunol Res
; 2020: 8820377, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33294467
7.
Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation.
Leuk Lymphoma
; 61(1): 91-97, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31512531
8.
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation.
Blood Cancer J
; 11(3): 49, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33664234